Tamsulosin Hydrochloride Capsule
Product Images NDC 71610-724

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Tamsulosin Hydrochloride (NDC 71610-724). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle Label 0.4 mg (71610 0724 30)

Label for Tamsulosin Hydrochloride 0.4 mg capsules, containing 30 capsules. The label includes storage instructions, manufacturer information (Cadila Healthcare Ltd., Ahmedabad and packaging by Aphena Pharma Solutions, Cookeville, TN), and a barcode along with NDC number 71610-0724-30.*

FDA Label Image

Aphena Pharma Solutions (TN)

FDA Label Image

Structured Formula For Tamsulosin (Bcb383f3 196a 4332 9904 08dd8b5da9bd 01)

Chemical structure of Tamsulosin Hydrochloride, showing its molecular arrangement with specific functional groups, including methoxy, sulfonamide, and ethoxy substituents, as well as its hydrochloride salt form.*

FDA Label Image

Structured Formula For Tamsulosin (Bcb383f3 196a 4332 9904 08dd8b5da9bd 02)

A pharmacokinetic concentration-time graph showing plasma concentration (ng/mL) of Tamsulosin Hydrochloride over 36 hours. The graph compares plasma levels for fasted and fed states, with the fasted condition peaking higher and earlier than the fed condition.*

FDA Label Image

Structured Formula For Tamsulosin (Bcb383f3 196a 4332 9904 08dd8b5da9bd 03)

A line graph depicting mean change over 13 weeks of treatment with Tamsulosin Hydrochloride capsules in 0.4 mg and 0.8 mg doses versus placebo. The x-axis shows treatment duration in weeks, and the y-axis shows mean change. Data points indicate sample sizes at each time and highlight differences between the two treatment doses and placebo over time.*

FDA Label Image

Structured Formula For Tamsulosin (Bcb383f3 196a 4332 9904 08dd8b5da9bd 04)

A line graph showing mean change over time by duration of treatment (weeks) for Tamsulosin Hydrochloride 0.4 mg, 0.8 mg, and placebo groups. The x-axis represents treatment duration in weeks from 0 to 13 and LOCF, and the y-axis represents mean change. Three lines compare outcomes with different marker patterns corresponding to 0.8 mg, 0.4 mg, and placebo groups.*

FDA Label Image

Structured Formula For Tamsulosin (Bcb383f3 196a 4332 9904 08dd8b5da9bd 05)

A line graph depicting mean change in a measured variable (mL/sec) over weeks of treatment. The x-axis shows duration of treatment from baseline through 14 weeks, and the y-axis shows mean change values. Three treatment groups are compared: 0.8 mg, 0.4 mg, and placebo, each represented by different line styles and markers. Sample sizes for each time point are noted.*

FDA Label Image

Structured Formula For Tamsulosin (Bcb383f3 196a 4332 9904 08dd8b5da9bd 06)

A line graph showing mean change (mL/sec) over duration of treatment in weeks for Tamsulosin Hydrochloride capsules at 0.8 mg and 0.4 mg doses compared to placebo. The graph tracks changes at multiple time points up to 13 weeks, illustrating different responses between treatments.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.